Robert Rosen, President at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 446,600 shares at $40.17 ($17.4M) on 2018-06-29, disclosed to the SEC on 2018-07-03.
Open-market sale of $17.4M HRTX by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.14 | 75,661 | $3.0M | 17.0% |
| 2 | $39.14 | 75,661 | $3.0M | 17.0% |
| 3 | $40.17 | 51,696 | $2.1M | 11.9% |
| 4 | $40.17 | 51,696 | $2.1M | 11.9% |
| 5 | $41.39 | 2,112 | $87K | 0.5% |
| 6 | $41.39 | 2,112 |
| $87K |
| 0.5% |
| 7 | $38.13 | 92,131 | $3.5M | 20.2% |
| 8 | $38.13 | 92,131 | $3.5M | 20.2% |
| 9 | $38.75 | 3,400 | $132K | 0.8% |
| Total | $38.98 avg | 446,600 | $17.4M | 100% |
| Filing → |